COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE
The present disclosure relates to methods of administering a compound for treating a patient suffering from thyroid disease and various thyroid-related disorders, including hyperthyroid and hypothyroid. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.
1 . A method for treating a thyroid disease comprising: administering an effective amount of a composition to a patient suffering from the thyroid disease, wherein the composition comprises:
1.5 to 3.5 mg of B6;
50 to 100 mcg of B12;
500 to 700 mcg of iodine;
50 to 150 mcg of selenium;
4 to 12 mg of zinc;
0.5 to 2 mg of manganese;
25 to 125 mcg to molybdenum;
450 to 600 mg of ashwaganda root powder;
102 to 170 mg of an extract selected from the group consisting of polygonum root extract, a grape seed extract, or combinations thereof; and
100 to 300 mg of at least one digestive enzyme.
2 . The method of claim 1 , wherein the thyroid disease is selected from the group consisting of hyperthyroid, and hypothyroid.
3 . The method of claim 1 , wherein the composition is administered orally in the form of a capsule.
4 . The method of claim 3 , wherein the method further comprises administering between 2 and 3 capsules of the composition to the patient per day.
5 . The method of claim 1 , wherein the composition administered to the patient further comprises 40 to 110 mg of L-Tyrosine.
6 . The method of claim 5 , wherein the composition administered to the patient further comprises 20 to 80 mg of mullein leaf
7 . The method of claim 6 , wherein the digestive enzyme is DPP-IV.
8 . A method for treating a thyroid disease by administering to a patient in need thereof a composition, wherein the composition comprises:
2 mg of B6;
90 mcg of B12;
500 mcg of iodine;
150 mcg of selenium;
10 mg of zinc;
2 mg of manganese;
75 mcg of molybdenum;
450 mg of ashwagandha root powder;
102 mg of polygonum root extract;
200 mg of DPP-IV;
75 mg of L-Tyrosine;
50 mg of mullein leaf; and
wherein the composition is administered in the form of a single capsule.
9 . The method of claim 8 , wherein the B12 administered to the patient is in the form of methylcobalamin.
10 . The method of claim 8 , wherein the composition administered to the patient further comprises calcium phosphate.
11 . The method of claim 8 , wherein the composition administered to the patient further comprises copper gluconate.
12 . The method of claim 8 , wherein the composition administered to the patient further comprises hydroxypropyl methylcellulose.
13 . The method of claim 8 , wherein the composition administered to the patient does not comprise additives selected from the group consisting of gluten, wheat, egg, peanuts, tree nuts, dairy, sugar, com, soy, artificial colors, preservatives, fish and shellfish.
14 . The method of claim 8 , wherein the composition administered to the patient further comprises at least one palatability agent.
15 . The method of claim 14 , wherein the palatability agent is selected from the group consisting of plant oils, plant hydrolysates, yeast, and yeast hydrolysates.
16 . The method of claim 15 , wherein the thyroid disease is selected from the group consisting of hyperthyroid, and hypothyroid.
17 . The method of claim 15 , wherein the composition is administered to the patient as a dietary supplement.